Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations

Michael A. Gibney, Christina H. Arce, Karen J. Byron, Laurence J. Hirsch

Comparative glycemic control, safety and patient ratings for a new 4 mm\32G insulin pen needle in adults with diabetes

Laurence J. Hirsch, Michael A. Gibney, John Albanese, Shankang Qu, Kenneth Kassler-Taub, Leslie J. Klaff, Timothy S. Bailey

Optimizing insulin injection needles

Shamsa Ali, Vivian Fonseca

Clinical articles and editorials

Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases

Hania Szajewska, Andrea Horvath

Undertreatment of hypercholesterolemia

Stella S. Daskalopoulou, Robert J. Doonan, Dimitri P. Mikhailidis

Health perceptions and clinical characteristics of relapsing-remitting multiple sclerosis patients: baseline data from an international clinical trial

D. Robinson Jr., N. Zhao, T. Gathany, L.-L. Kim, D. Cella, D. Revicki

A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial

S. Mercadante, L. Radbruch, A. Davies, P. Poulain, T. Sitte, P. Perkins, T. Colberg, M.A. Camba

Opioid switching and rotation in primary care: implementation and clinical utility

Neal E. Slatkin

Can the bowel substitute for the kidney in advanced renal failure?

Eli A. Friedman

Statins and venous thromboembolism: a novel effect of statins?

Kosmas I. Paraskevas, Nikolaos Bessias, Theodossios P. Perdikides, Dimitri P. Mikhailidis

Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS study

V. G. Athyros, A. Karagiannis, A. I. Hatzitolios et al.

Sustained effect of the aromatase inhibitors anastrozole and letrozole on endometrial thickness in patients with endometrial hyperplasia and endometrial carcinoma

L. C. Barker, , I. R. Brand and , S. M. Crawford

Burden of atrial fibrillation

Chee W. Khoo and , Gregory Y. H. Lip

Contents and Preface for Supplement: Recognition and management of some possible consequences of stopping smoking

Guest Editor: Peter Hajek

Statin discontinuation: an underestimated risk

Konstantinos Tziomalos, Vasilios G. Athyros, Dimitri P. Mikhailidis

Anticoagulation in atrial fibrillation: the trials and tribulations of keeping within therapeutic range

Jaspal S. Taggar, Gregory Y. H. Lip

Patient use of dietary supplements: a clinician's perspective

Richard Sadovsky, Nancy Collins, Ann P. Tighe, Stephen A. Brunton, Richard Safeer

Lipid abnormalities and cardiovascular risk in the elderly

Haralampos J. Milionis, Moses S. Elisaf, Dimitri P. Mikhailidis

Is NICE infallible? A qualitative study of its assessment of treatments for attention-deficit/hyperactivity disorder (ADHD)

Michael Schlander

Supplementary material

C-reactive protein (CRP): more than just an innocent bystander?

Kosmas I. Paraskevas, Dimitri P. Mikhailidis

Treating bleeding oesophageal varices with vasoactive agents: good value for money?

J. N. Plevris, P. C. Hayes

Long-term glycemic control through preserved β-cell function

Richard E. Pratley

Shape of the Nations survey and attitudes to cardiometabolic risk

Anthony S. Wierzbicki, Emmanuel S. Ganotakis, Dimitri P. Mikhailidis

Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia

Stella S. Daskalopoulou, Dimitri P. Mikhailidis

Atrial fibrillation post-cardiac surgery: changing perspectives

Eduard Shantsila, Timothy Watson and Gregory Y. H. Lip

Good publication practice articles:

International Society for Medical Publication Professionals (ISMPP)position statement: the role of the professional medical writer

Robert Norris, Aly Bowman, Jean M. Fagan, Eileen R. Gallagher, Anna B. Geraci, Art Gertel, Laurence Hirsch, Philip D. Ross, Thomas P. Stossel, Keith Veitch, David Woods

Trial registration and results disclosure: impact of US legislation on sponsors, investigators, and medical journal editors

Laurence Hirsch

The need for trial identifiers

Elizabeth Wager

European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications

Adam Jacobs and Elizabeth Wager

Comments on European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications

MaryAnn Foote et al. / Adam Jacobs a and Elizabeth Wager

The involvement of professional medical writers in medical publications

Stella S. Daskalopoulou and Dimitri P. Mikhailidis

Good publication practice for pharmaceutical companies: why we need another set of guidelines [Editorial}

Elizabeth Wager, Elizabeth A. Field, Leni Grossman

Good publication practice for pharmaceutical companies [Guidelines]

Elizabeth Wager, Elizabeth A. Field, Leni Grossman

Journal related articles:

A fresh new look for CMRO

J. Magrann